M.D. ANDERSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory Neuroblastoma

Phase 2

Terminated

Conditions: Neuroblastoma

Interventions: Drug: Fludarabine
Drug: Cyclophosphamide
Biological: Natural Killer Cell Infusion
Drug: Mesna
Drug: Interleukin-2

First Posted Date: 2008-06-16

Last Posted Date: 2020-09-24

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 1

Registration Number: NCT00698009

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Lenalidomide in Combination With Rituximab in Treating Participants With Stage III/IV Indolent Non-Hodgkin Lymphoma

Phase 2

Completed

Conditions: Ann Arbor Stage IV Grade 1 Follicular Lymphoma
Ann Arbor Stage IV Grade 2 Follicular Lymphoma
Ann Arbor Stage III Grade 2 Follicular Lymphoma
Ann Arbor Stage III Small Lymphocytic Lymphoma
Ann Arbor Stage III Indolent Adult Non-Hodgkin Lymphoma
Ann Arbor Stage IV Marginal Zone Lymphoma
Ann Arbor Stage III Grade 1 Follicular Lymphoma
Ann Arbor Stage III Marginal Zone Lymphoma
Ann Arbor Stage IV Indolent Adult Non-Hodgkin Lymphoma
Ann Arbor Stage IV Small Lymphocytic Lymphoma

Interventions: Drug: Lenalidomide
Biological: Rituximab

First Posted Date: 2008-06-12

Last Posted Date: 2021-10-20

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 156

Registration Number: NCT00695786

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

Inflammatory Cytokines in Symptom Production in Multiple Myeloma

Completed

Conditions: Multiple Myeloma

Interventions: Behavioral: Questionnaire
Behavioral: Neurocognitive Testing
Behavioral: Neurosensory Testing

First Posted Date: 2008-06-02

Last Posted Date: 2019-05-29

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 491

Registration Number: NCT00688168

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Correlation of MR Thermal Imaging to Actual Size of Ablation During Laser Ablation Therapy

Phase 4

Completed

Conditions: Bone Metastases
Advanced Cancer

Interventions: Procedure: Laser Ablation
Procedure: Magnetic Resonance Thermal Imaging

First Posted Date: 2008-06-02

Last Posted Date: 2017-09-15

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 24

Registration Number: NCT00688038

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous Polyposis

Phase 1

Completed

Conditions: Colorectal Cancer
Precancerous Condition

Interventions: Drug: celecoxib
Other: placebo

First Posted Date: 2008-05-28

Last Posted Date: 2018-11-07

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 22

Registration Number: NCT00685568

Locations: 🇺🇸
University of Texas Medical School at Houston, Houston, Texas, United States
🇺🇸
Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States
🇺🇸
M. D. Anderson Cancer Center at University of Texas, Houston, Texas, United States

and more 1 locations

Literacy and Smoking Risk Communications

Not Applicable

Active, not recruiting

Conditions: Smoking

Interventions: Behavioral: Focus Group
Behavioral: Questionnaire

First Posted Date: 2008-05-26

Last Posted Date: 2024-07-03

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 494

Registration Number: NCT00684437

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Lenalidomide (Revlimid) for the Treatment of Refractory Cancer Pain

Phase 2

Terminated

Conditions: Advanced Cancer
Pain

Interventions: Drug: Lenalidomide

First Posted Date: 2008-05-26

Last Posted Date: 2013-01-28

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 4

Registration Number: NCT00684242

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Perioperative Kinetics of Reactive Hyperemia Using Noninvasive Digital Thermal Monitoring

Completed

Conditions: Abdominal Surgery
Thoracic Surgery

Interventions: Other: Endothelial Function Test

First Posted Date: 2008-05-23

Last Posted Date: 2012-07-31

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 59

Registration Number: NCT00683150

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Patient and Family Decision Making in the Palliative Care Setting

Not Applicable

Completed

Conditions: Advanced Cancer

Interventions: Behavioral: Interview
Behavioral: Questionnaire

First Posted Date: 2008-05-23

Last Posted Date: 2016-02-19

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 780

Registration Number: NCT00682994

Locations: 🇦🇷
Fundacion FEMEBA - Programa Argentino de Medicina Paliativa - Hospital Tornu, Buenos Aires, Argentina
🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States
🇨🇱
Dr. Sotero del Rio Hospital - Catholic University of Chile, Santiago, Chile

and more 1 locations

Quantitative Analysis of Outcomes in Breast Reconstruction

Completed

Conditions: Breast Cancer

Interventions: Behavioral: Questionnaire
Procedure: Digital Imaging

First Posted Date: 2008-05-14

Last Posted Date: 2021-04-14

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 224

Registration Number: NCT00677430

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Home Terms & Conditions Privacy Policy